I think you'd be surprised at the infrastructure that out there for plasma collection. I was doing due diligence on one of these companies a few years back and was surprised to learn that the pharmaceutical company owns thousands of plasma collection clinics. The IV Ig market is quite large.

That said, you're right, this could never be used with every infected patient, but companies could probably produce enough for the sickest patients.